Studies from Yonsei University Health System in the Area of Breast Cancer Published [Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC): Primary ...]

Media coverage

• Title	Studies from Yonsei University Health System in the Area of Breast Cancer Published [Palbociclib (P) plus tamoxifen (TAM) ± goserelin in women with hormone receptor-positive (HR+)/HER2-negative (HER2-) advanced breast cancer (ABC): Primary ...]
  Media name/outlet	NewsRx Women's Health Daily
  Country/Territory	United States
  Date	6/26/23
  Persons	Min-Hyun Kim